Clinical trial Recruiting at 1 site Observational Ages 18 to 49 Women only

How menstrual cups, tampons, and pads affect vaginal microbiota and immunity

Official title: Impact of the Use of Internal Menstrual Protections on Immunity and Vaginal Microbiota

Run by Centre National de la Recherche Scientifique, France · NCT07199998 · Data updated 2026-11-12

This project will see if using menstrual cups, tampons, or pads is linked to changes in vaginal bacteria, local immune responses, or recurrence of common vaginal infections in adult women.

Quick facts

Study typeObservational
Ages18 Years to 49 Years
SexWomen only
Enrollment300 (estimated)
SponsorCentre National de la Recherche Scientifique, France
Academic / other
Locations1 site (Paris, Île-de-France Region)
StatusRecruiting
StartedApril 7, 2026
Main results expectedMarch 2027
Study endsMarch 2027
Registry record updatedApril 9, 2026
Trial IDNCT07199998 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 18–49 who have menstruated, are in generally good health, covered by national health insurance, able to consent and attend study visits, and who refrain from vaginal sex for 72 hours before sampling are ideal candidates.

Probably not a fit

People who are pregnant or breastfeeding, HIV-positive, recently diagnosed with chlamydia or syphilis, have significant hormonal or menstrual disorders, or are on recent immunomodulatory treatment are excluded and unlikely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The project combines a large online survey of 1,500–1,800 participants about menstrual product habits and self-reported urogenital symptoms with a clinical study of about 300 women grouped by primary menstrual protection (menstrual cup, tampon, or external pad). Clinical participants will undergo gynecological exams and provide vaginal, cervical, urine, and blood samples for microbiome sequencing, immune profiling (cytokines and antibodies), and toxicological assays for environmental pollutants. Analyses will compare microbial composition, local immune markers, and exposure levels across product groups and correlate findings with infection history and symptoms. The work is led by the CNRS in collaboration with Institut Alfred Fournier in Paris.

Why it matters

Potential benefit: If successful, results could help women choose safer menstrual products and inform guidance to reduce recurrent vaginal infections.

How similar studies have gone: Small prior studies have suggested menstrual products can influence vaginal microbiota, but comprehensive clinical and toxicological comparisons across product types remain limited and partly novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Willingness to comply with all study procedures and availability for the duration of the study.
* Female, aged 18 to 49 years.
* In general good health, as determined by medical history.
* Covered by the national health insurance system.
* Willing to sign a written informed consent form.
* Has already experienced menstruation prior to the start of the study.
* No vaginal sexual intercourse within 72 hours before the study visit.
* Has had at least 6 menstrual periods in the past 12 months.

Exclusion Criteria:

* HIV infection.
* Positive diagnosis for chlamydia or syphilis at screening or within 4 weeks prior to screening.
* History of hormonal disorders or menstrual cycle irregularities.
* Metrorrhagia.
* Pregnancy or breastfeeding.
* Family members or close relatives of the clinical or scientific team.
* Treatment with any medication for chronic inflammatory disease or chronic conditions (e.g., cancer, arthritis, transplantation) within the past 12 months.
* Participation in an ongoing clinical trial.
* Receiving or having received antibiotic treatment within the 4 weeks prior to the study.
* Refusal to be informed in case of detected abnormalities.
* Indistinct use of both tampons and menstrual cups.
* Never having had vaginal penetrative intercourse.

Where it's running

  • Institut Alfred Fournier
    Paris, Île-de-France Region, France
    Recruiting

Study contacts

  • Principal investigator: Samuel Alizon, Doctor in Biology — Centre National de la Recherche Scientifique, France
  • Study coordinator: Samuel Alizon, Dr
  • Email: samuel.alizon@cnrs.fr
  • Phone: +33(4)144271667

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.